Eve Burstein
Stock Analyst at Bernstein
(2.61)
# 2,139
Out of 5,049 analysts
24
Total ratings
46.15%
Success rate
22.65%
Average return
Main Sectors:
Stocks Rated by Eve Burstein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Market Perform | $145 → $125 | $147.49 | -15.25% | 5 | Apr 16, 2025 | |
| NTRA Natera | Maintains: Outperform | $160 → $200 | $198.48 | +0.77% | 4 | Jan 10, 2025 | |
| RVTY Revvity | Maintains: Outperform | $150 → $145 | $89.52 | +61.97% | 2 | Nov 5, 2024 | |
| WAT Waters | Maintains: Market Perform | $345 → $360 | $371.16 | -3.01% | 2 | Nov 4, 2024 | |
| EXAS Exact Sciences | Maintains: Outperform | $75 → $90 | $67.22 | +33.89% | 2 | Oct 30, 2024 | |
| GH Guardant Health | Maintains: Outperform | $40 → $35 | $96.25 | -63.64% | 2 | Oct 30, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Market Perform | $625 → $620 | $565.98 | +9.54% | 3 | Oct 24, 2024 | |
| PACB Pacific Biosciences of California | Maintains: Outperform | $9 → $2.5 | $1.78 | +40.45% | 2 | Apr 18, 2024 | |
| AVTR Avantor | Initiates: Market Perform | $22 | $11.32 | +94.35% | 1 | Sep 28, 2023 | |
| ILMN Illumina | Initiates: Underperform | $111 | $121.11 | -8.35% | 1 | Sep 28, 2023 |
Agilent Technologies
Apr 16, 2025
Maintains: Market Perform
Price Target: $145 → $125
Current: $147.49
Upside: -15.25%
Natera
Jan 10, 2025
Maintains: Outperform
Price Target: $160 → $200
Current: $198.48
Upside: +0.77%
Revvity
Nov 5, 2024
Maintains: Outperform
Price Target: $150 → $145
Current: $89.52
Upside: +61.97%
Waters
Nov 4, 2024
Maintains: Market Perform
Price Target: $345 → $360
Current: $371.16
Upside: -3.01%
Exact Sciences
Oct 30, 2024
Maintains: Outperform
Price Target: $75 → $90
Current: $67.22
Upside: +33.89%
Guardant Health
Oct 30, 2024
Maintains: Outperform
Price Target: $40 → $35
Current: $96.25
Upside: -63.64%
Thermo Fisher Scientific
Oct 24, 2024
Maintains: Market Perform
Price Target: $625 → $620
Current: $565.98
Upside: +9.54%
Pacific Biosciences of California
Apr 18, 2024
Maintains: Outperform
Price Target: $9 → $2.5
Current: $1.78
Upside: +40.45%
Avantor
Sep 28, 2023
Initiates: Market Perform
Price Target: $22
Current: $11.32
Upside: +94.35%
Illumina
Sep 28, 2023
Initiates: Underperform
Price Target: $111
Current: $121.11
Upside: -8.35%